These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32345264)

  • 21. CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel.
    Jeong TD; Kim SM; Kim HJ; Lee W; Kwon SU; Min WK; Kang DW; Chun S
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):440-6. PubMed ID: 25529343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention.
    Liu G; Yang S; Chen S
    Medicine (Baltimore); 2020 Mar; 99(11):e19143. PubMed ID: 32176040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body weight, CYP2C19, and P2Y12 receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance.
    Li Z; Dong W; Yang D; Sun L; He X; Hu H; Zhang J; Wang C; Li Y; Zhao M; Kong Y; Wang Y
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1517-1527. PubMed ID: 32632713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.
    Liang ZY; Han YL; Zhang XL; Li Y; Yan CH; Kang J
    EuroIntervention; 2013 Jul; 9(3):316-27. PubMed ID: 23872648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population.
    Yi X; Wang C; Liu P; Fu C; Lin J; Chen Y
    J Neurol; 2016 Aug; 263(8):1612-9. PubMed ID: 27260294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variants in matrix metalloproteinase-9 gene are associated with hemorrhagic transformation in acute ischemic stroke patients with atherothrombosis, small artery disease, and cardioembolic stroke.
    Yi X; Sui G; Zhou Q; Wang C; Lin J; Chai Z; Zhou J
    Brain Behav; 2019 Jun; 9(6):e01294. PubMed ID: 31074588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients.
    Namazi S; Kojuri J; Khalili A; Azarpira N
    Biochem Pharmacol; 2012 Apr; 83(7):903-8. PubMed ID: 22265638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions among
    Yi X; Han Z; Zhou Q; Lin J; Wang C
    Ther Adv Neurol Disord; 2017 Mar; 10(3):161-170. PubMed ID: 28344655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of CYP2C19, P2Y12, and ABCB1 polymorphisms and phenotypic response to clopidogrel in healthy Indian adults.
    Sridharan K; Kataria R; Tolani D; Bendkhale S; Gogtay NJ; Thatte UM
    Indian J Pharmacol; 2016; 48(4):350-354. PubMed ID: 27756942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance.
    Siasos G; Oikonomou E; Vavuranakis M; Kokkou E; Mourouzis K; Tsalamandris S; Zaromitidou M; Kioufis S; Tsigkou V; Deftereos S; Stefanadis C; Tousoulis D
    Cardiology; 2017; 137(2):104-113. PubMed ID: 28329746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
    Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel.
    Wang Y; Cai H; Zhou G; Zhang Z; Liu X
    J Neurol Sci; 2016 Oct; 369():216-219. PubMed ID: 27653892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with clopidogrel resistance and clinical outcomes in ischemic cerebrovascular disease: A retrospective study.
    Wu Y; Shen H; Cai B; Chen C; Yin Q; Zhao Y; Zhou G
    J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107684. PubMed ID: 38518890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia.
    Zhu WY; Zhao T; Xiong XY; Li J; Wang L; Zhou Y; Gong ZL; Cheng SY; Liu Y; Shuai J; Yang QW
    Sci Rep; 2016 May; 6():25478. PubMed ID: 27137706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel.
    Xu K; Ye S; Zhang S; Yang M; Zhu T; Kong D; Chen J; Xu L; Li J; Zhu H; Wang F; Yang L; Zhang J; Fan Y; Ying L; Hu X; Zhang X; Chan NC; Li C
    Circ Cardiovasc Interv; 2019 May; 12(5):e007019. PubMed ID: 31018667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.
    Han SW; Kim YJ; Ahn SH; Seo WK; Yu S; Oh SH; Kim YN; Lee KY;
    Int J Stroke; 2016 Jun; 11(4):485-91. PubMed ID: 26763917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline P2Y12 reactivity, kidney function, and CYP2C19 genotype determine clopidogrel responsiveness in acute stroke.
    Lee YC; Liao YC; Lin CJ; Chung CP
    Sci Rep; 2023 May; 13(1):8085. PubMed ID: 37208337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of CYP2C19 genetic polymorphism on clopidogrel response in patients with ischemic stroke from Saudi Arabia.
    Alhazzani AA; Munisamy M; Karunakaran G
    Neurosciences (Riyadh); 2017 Jan; 22(1):31-37. PubMed ID: 28064328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Between a rock and a hard place: a high-risk patient with resistance to multiple P2Y
    Davis BH; Dillon C; Cai A; Williams Iii LA; Pamboukian SV; Limdi NA
    Pharmacogenomics; 2019 May; 20(7):475-481. PubMed ID: 31124414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways.
    Máchal J; Hlinomaz O
    Curr Vasc Pharmacol; 2019; 17(1):35-40. PubMed ID: 29412111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.